Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann

[1]  M. Kramer,et al.  Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid , 1992, The British journal of dermatology.

[2]  M. Kramer,et al.  Complement and plasminogen: pathways in inflammation. , 1992, Behring Institute Mitteilungen.

[3]  M. Kramer,et al.  Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro. , 1992, Experimental cell research.

[4]  S. Burge,et al.  Plasminogen binding sites in normal human skin , 1992, The British journal of dermatology.

[5]  K. Hajjar.  The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. , 1991, The Journal of biological chemistry.

[6]  D. Belin,et al.  mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. , 1990, The Journal of investigative dermatology.

[7]  D. Belin,et al.  Tissue plasminogen activator in psoriasis. , 1990, The Journal of investigative dermatology.

[8]  A. Vaheri,et al.  Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion. , 1990, Cell regulation.

[9]  P. Jensen,et al.  A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration. , 1990, Cell regulation.

[10]  M. Mayer,et al.  Biochemical and biological aspects of the plasminogen activation system. , 1990, Clinical biochemistry.

[11]  L. Magnelli,et al.  Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. , 1990, The Journal of investigative dermatology.

[12]  P. Jensen,et al.  Urokinase and tissue type plasminogen activators in human keratinocyte culture. , 1990, Experimental cell research.

[13]  K. Hajjar,et al.  Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. , 1990, The Journal of biological chemistry.

[14]  A. Vaheri,et al.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.

[15]  J. Wilkinson,et al.  Role of plasminogen activator in pemphigus vulgaris. , 1989, The American journal of pathology.

[16]  K. Hashimoto,et al.  Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. , 1989, The Journal of investigative dermatology.

[17]  K. Takamori,et al.  The Role of Proteases in the Pathogenesis of Bullous Dermatoses , 1988, International journal of dermatology.

[18]  M. Mitsui,et al.  Aprotinin inhibition of experimental pemphigus in Balb‐c mice following passive transfer of pemphigus foliaceus serum , 1988, Clinical and experimental dermatology.

[19]  M. Kramer,et al.  Application of novel monoclonal antibodies in the purification, quantification, and immunohistological localization of the proteinase inhibitor α2-macroglobulin , 1988 .

[20]  P. Jensen,et al.  Epidermal plasminogen activator is abnormal in cutaneous lesions. , 1988, The Journal of investigative dermatology.

[21]  E. Plow,et al.  Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis , 1988 .

[22]  M. Kramer,et al.  The antiproteolytic compound α2 in human skin , 1988, Archives of Dermatological Research.

[23]  M. Kramer,et al.  A monoclonal antibody recognizing plasminogen and plasmin—altered reactivity in psoriatic lesions , 1987, The British journal of dermatology.

[24]  P. Jensen,et al.  Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. , 1987, The Journal of investigative dermatology.

[25]  E. Jaffe,et al.  Binding of plasminogen to cultured human endothelial cells. , 1986, The Journal of biological chemistry.

[26]  R. Silverstein,et al.  Binding of plasminogen to extracellular matrix. , 1986, The Journal of biological chemistry.

[27]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[28]  P. Gaffney,et al.  Bioimmunoassay (BIA) of Tissue Plasminogen Activator (t-PA) and Its Specific Inhibitor (t-PA/INH) , 1985, Thrombosis and Haemostasis.

[29]  A. Vaheri,et al.  Urokinase‐type plasminogen activator and its inhibitor secreted by cultured human monocyte‐macrophages , 1985, Journal of cellular physiology.

[30]  G. Kavli,et al.  The pattern of lysosomal, cytosolic and plasma membrane enzymes in epidermis, dermis and suction blister fluid after ultraviolet radiation. , 1983, The British journal of dermatology.

[31]  S. Alexander.  (16) Non‐bullous ichthyosiform erythroderma , 1983 .

[32]  P. McKee,et al.  The binding of human plasminogen to fibrin and fibrinogen. , 1983, The Journal of biological chemistry.

[33]  R. Isseroff,et al.  Plasminogen is present in the basal layer of the epidermis. , 1983, The Journal of investigative dermatology.

[34]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[35]  T. Starzl,et al.  Synthesis of human plasminogen by the liver. , 1980, Science.

[36]  J. Vassalli,et al.  Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors , 1977, The Journal of experimental medicine.

[37]  J. Vassalli,et al.  Plasmin induces acantholysis in skin organ cultures , 2004, Archives of Dermatological Research.

[38]  M. Schmitt,et al.  Monoclonal Antibodies Against Plasminogen Activators and Plasmin(ogen) , 1992 .

[39]  M. Kramer,et al.  The antiproteolytic compound alpha 2-macroglobulin in human skin. , 1988, Archives of dermatological research.

[40]  K. Danø,et al.  Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. , 1987, The Journal of investigative dermatology.

[41]  M. Cubellis,et al.  The receptor for urokinase‐plasminogen activator , 1986, Journal of cellular biochemistry.

[42]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[43]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[44]  K. Robbins,et al.  Human plasmin. , 1981, Methods in enzymology.